Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Kozma

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Visual Neuroscience|February 24, 2004
Contour integration in amblyopic monkeysPetra Kozma, Lynne Kiorpes
The British Journal of Ophthalmology|March 15, 2022
Resolution of outer retinal abnormalities in eyes with vitreomacular traction without macular hole in the OASIS trialAkshay S Thomas, Luc Duchateau, Petra Kozma-Wiebe, et al.
Ophthalmology|August 9, 2016
Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized TrialPravin U Dugel, Michael Tolentino, Leonard Feiner, et al.
Retina (Philadelphia, Pa.)|December 6, 2017
THE OASIS MP-1 SUBSTUDY: Characterization of the Effect of Ocriplasmin on Microperimetry ParametersSriniVas R Sadda, Pravin U Dugel, Victor H Gonzalez, et al.
Retina (Philadelphia, Pa.)|January 16, 2007
Persistent cone dysfunction in acute exudative polymorphous vitelliform maculopathyPetra Kozma, Kirsten G Locke, Yi-Zhong Wang, et al.
BMC Geriatrics|June 6, 2021
Contribution of IQ in young adulthood to the associations of education and occupation with cognitive ability in older ageInsa Feinkohl, Petra Kozma, Friedrich Borchers, et al.
Translational Vision Science & Technology|December 23, 2021
Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular EdemaPravin U Dugel, Arshad M Khanani, Brian B Berger, et al.
Retina (Philadelphia, Pa.)|June 5, 2020
OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT StudyDavid H W Steel, Niall Patton, Theodor Stappler, et al.
Retina (Philadelphia, Pa.)|February 16, 2017
EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG SubstudyDavid G Birch, Matthew S Benz, Daniel M Miller, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 23, 2021
Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)Kimberly A Drenser, Dante J Pieramici, Joseph M Gunn, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Visual Neuroscience|February 24, 2004
Contour integration in amblyopic monkeysPetra Kozma, Lynne Kiorpes
The British Journal of Ophthalmology|March 15, 2022
Resolution of outer retinal abnormalities in eyes with vitreomacular traction without macular hole in the OASIS trialAkshay S Thomas, Luc Duchateau, Petra Kozma-Wiebe, et al.
Ophthalmology|August 9, 2016
Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized TrialPravin U Dugel, Michael Tolentino, Leonard Feiner, et al.
Retina (Philadelphia, Pa.)|December 6, 2017
THE OASIS MP-1 SUBSTUDY: Characterization of the Effect of Ocriplasmin on Microperimetry ParametersSriniVas R Sadda, Pravin U Dugel, Victor H Gonzalez, et al.
Retina (Philadelphia, Pa.)|January 16, 2007
Persistent cone dysfunction in acute exudative polymorphous vitelliform maculopathyPetra Kozma, Kirsten G Locke, Yi-Zhong Wang, et al.
BMC Geriatrics|June 6, 2021
Contribution of IQ in young adulthood to the associations of education and occupation with cognitive ability in older ageInsa Feinkohl, Petra Kozma, Friedrich Borchers, et al.
Translational Vision Science & Technology|December 23, 2021
Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular EdemaPravin U Dugel, Arshad M Khanani, Brian B Berger, et al.
Retina (Philadelphia, Pa.)|June 5, 2020
OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT StudyDavid H W Steel, Niall Patton, Theodor Stappler, et al.
Retina (Philadelphia, Pa.)|February 16, 2017
EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG SubstudyDavid G Birch, Matthew S Benz, Daniel M Miller, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 23, 2021
Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)Kimberly A Drenser, Dante J Pieramici, Joseph M Gunn, et al.
Pageof 2